Indrayani Biotech Ltd.
|
Ratio Analysis
|
|
You can view the
Ratio Analysis
for the last 5 years.
Market Cap. (Rs.)
|
256.87 Cr.
|
P/BV
|
4.50
|
Book Value (Rs.)
|
12.55
|
52 Week High/Low (Rs.)
|
100/47
|
FV/ML
|
10/1
|
P/E(X)
|
29.41
|
Bookclosure
|
20/09/2023
|
EPS (Rs.)
|
1.92
|
Div Yield (%)
|
0.00
|
|
Months | 12 | 12 | 12 | 12 | 12 |
Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | |
PER SHARE RATIOS | | | | | |
| | | | | |
Basic EPS (Rs.) | 2.55 | 1.30 | -3.25 | 2.21 | -0.17 |
Diluted EPS (Rs.) | 2.05 | 1.30 | -3.25 | 2.21 | -0.17 |
Cash EPS (Rs.) | 4.46 | 1.49 | -3.14 | 5.00 | 0.59 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 11.42 | 7.18 | 5.87 | 0.69 | 9.52 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 11.42 | 7.18 | 5.87 | 0.69 | 9.52 |
Revenue From Operations / Share (Rs.) | 47.60 | 17.99 | 6.16 | 136.93 | 156.95 |
PBDIT / Share (Rs.) | 6.34 | 2.04 | -1.37 | 8.16 | 1.69 |
PBIT / Share (Rs.) | 5.36 | 1.85 | -1.50 | 5.37 | 0.92 |
PBT / Share (Rs.) | 3.60 | 1.30 | -3.28 | 2.21 | 0.07 |
Net Profit / Share (Rs.) | 3.48 | 1.30 | -3.28 | 2.21 | -0.17 |
NP After MI And SOA / Share (Rs.) | 2.55 | 1.30 | -3.25 | 2.21 | -0.17 |
| | | | | |
PROFITABILITY RATIOS | | | | | |
| | | | | |
PBDIT Margin (%) | 13.32 | 11.35 | -22.22 | 5.95 | 1.07 |
PBIT Margin (%) | 11.27 | 10.28 | -24.40 | 3.92 | 0.58 |
PBT Margin (%) | 7.55 | 7.23 | -53.19 | 1.61 | 0.04 |
Net Profit Margin (%) | 7.32 | 7.23 | -53.19 | 1.61 | -0.11 |
NP After MI And SOA Margin (%) | 5.36 | 7.21 | -52.73 | 1.61 | -0.11 |
Return on Networth / Equity (%) | 19.06 | 18.37 | -56.39 | 318.34 | -1.84 |
Return on Capital Employeed (%) | 21.84 | 19.83 | -18.21 | 5.18 | 9.23 |
Return On Assets (%) | 5.60 | 8.63 | -27.76 | 1.56 | -0.52 |
Long Term Debt / Equity (X) | 0.64 | 0.28 | 0.41 | 27.38 | 0.00 |
Total Debt / Equity (X) | 1.37 | 0.74 | 0.78 | 54.18 | 0.52 |
Asset Turnover Ratio (%) | 1.57 | 1.30 | 0.46 | 0.00 | 0.00 |
| | | | | |
LIQUIDITY RATIOS | | | | | |
| | | | | |
Current Ratio (X) | 1.08 | 0.97 | 0.72 | 1.03 | 0.78 |
Quick Ratio (X) | 0.90 | 0.89 | 0.72 | 1.03 | 0.78 |
Inventory Turnover Ratio (X) | 14.87 | 0.00 | 0.00 | 0.00 | 0.00 |
| | | | | |
COVERAGE RATIOS | | | | | |
| | | | | |
Interest Coverage Ratio (%) | 3.91 | 3.72 | -2.39 | 2.58 | 1.98 |
Interest Coverage Ratio (Post Tax) (%) | 3.24 | 3.37 | -2.62 | 1.70 | 0.79 |
| | | | | |
VALUATION RATIOS | | | | | |
| | | | | |
Enterprise Value (Cr.) | 255.64 | 121.18 | 36.95 | 15.38 | 2.45 |
EV / Net Operating Revenue (X) | 1.57 | 1.97 | 1.75 | 0.30 | 0.04 |
EV / EBITDA (X) | 11.78 | 17.33 | -7.88 | 5.17 | 3.92 |
MarketCap / Net Operating Revenue (X) | 1.19 | 1.70 | 1.03 | 0.06 | 0.03 |
Price / BV (X) | 4.22 | 4.32 | 1.10 | 12.01 | 0.51 |
Price / Net Operating Revenue (X) | 1.19 | 1.70 | 1.03 | 0.06 | 0.03 |
EarningsYield | 0.04 | 0.04 | -0.51 | 0.26 | -0.03 |